Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.870 AUD | -1.29% |
|
+3.31% | +3.15% |
07-08 | Australia shares end flat after RBA stuns with steady rates | RE |
07-02 | AMP Says to Defend Proceedings Filed by Dexus Unit Over Sale of New South Wales Shopping Center | MT |
Summary: DEXUS
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to MSCI, the company's ESG score for its industry is good.
Highlights: DEXUS
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses: DEXUS
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings Chart: DEXUS
Source: Surperformance
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
4.86B | |||||
10.66B | |||||
5.8B | |||||
4.88B | |||||
4.34B | |||||
4.33B | |||||
- | 4.32B | ||||
4.09B | |||||
3.87B | |||||
Average | 5.24B | ||||
Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
-
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- DXS Stock
- Ratings DEXUS
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition